UBS bearish on Scor as reinsurance pricing outlook weighs on earnings
UBS downgraded French reinsurer Scor to “sell” from “neutral” and cut its price target 6% to €32.50 from €34.50, citing September Monte Carlo Rendez-vous and a Dec. 3 capital markets day as potential earnings and distribution delays. UBS lowered EPS estimates for 2026-2028 and expects a higher solvency target, pushing buybacks out.
How this was made
The 30-second read
Why it matters
The downgrade and lower PT are driven by expected earnings pressure from investment income and IFIE unwind, plus a solvency-target increase that delays buybacks.
Market read
This is a sell-side catalyst note that can drive near-term repricing of Scor’s earnings trajectory and capital-return expectations into 2028.
What to watch
The article notes benign catastrophe activity could accelerate buybacks by 12-18 months, which may limit downside if realized.
Background
UBS frames the reinsurance outlook around upcoming industry catalysts and expects risk-adjusted pricing declines to revert closer to current-year levels.
Ticker impact
UBS downgraded Scor to “sell” and cut its price target to €32.50, citing Monte Carlo pricing pressure and a later buyback timeline.
Near-term downside bias versus consensus as investors reprice earnings and the timing of buybacks into 2028+.
The article provides specific UBS actions (downgrade, PT cut) plus concrete catalysts (Sept Monte Carlo, Dec capital markets day) and a quantified solvency-target range shift that affects buyback timing.
Market effects
Signals broader reinsurance pricing deterioration risk and higher scrutiny of terms and conditions, which can pressure sector multiples.
Primarily impacts European reinsurance sentiment and capital-return expectations.
Could influence global reinsurance risk premia and relative valuation for other reinsurers with similar solvency and reserve profiles.
Counterpoint
Scor’s YTD outperformance (up 28%) suggests some optimism is already priced; the downgrade may be partially offset if catastrophe activity remains benign.
Key entities
- companyScor
French reinsurer downgraded by UBS to “sell” with a reduced price target and revised earnings and capital-return timing assumptions.
- brokerUBS
Issued the downgrade and price-target cut, citing Monte Carlo Rendez-vous and a December capital markets day.
